Free Communications

« Back Print this page

  Personalized Program
The Personalized Program enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log in to use the Personalized Program.
 » Login
» Identification
» Help
   
  

Sunday, 28. June 2009

 next day » 
     
No. FC-01 - Free Communications
Time: 08.00-09.30
Room: Room 351
Topic: Affective Disorders (Unipolar)
Session title: Affective Disorders (Unipolar) I
  Michael Bauer, Germany Chair
  Zoltan Rihmer, Hungary Co-Chair
     
001 The effect of cortisol suppression on emotionasl stress responses in depressives and controls  
  Petra Netter, Germany Speaker
002 Cortical inhibitory deficits in major depressive disorder  
  Andrea Levinson, Canada Speaker
004 Increased self-focus in major depressive disorder is related to neural abnormalities in subcortical-cortical midline structures  
  Jutta Ernst, Switzerland Speaker
005 Altered negative bold responses in the default-mode network during emotion processing in depressed subjects  
  Simone Grimm, Switzerland Speaker
     
No. FC-02 - Free Communications
Time: 08.00-09.30
Room: Room 242A
Topic: Other
Session title: Other I
  David A. Gorelick, USA Chair
  Anu Kant Mital, India Co-Chair
     
001 Thai psychiatrists views on ICD-10, DSM -IV, and biological aspects of psychiatry  
  Pichet Udomratn, Thailand Speaker
002 Human imprinting and oral tactile fixation on a decoy  
  Elsie Mobbs, Australia Speaker
003 Gray matter changes in adolescents with Anorexia Nervosa restrictive type: A Voxel-Based-Morphometry study  
  Santino Gaudio, Italy Speaker
004 Enhancing the clinical utility of testing for drug metabolising enzyme (dme) status in real world psychiatric settings  
  Sylvester Wayne Miles, New Zealand Speaker
005 Changes of affinity of autoantibodies against alpha-melanocyte-stimulating hormone are involved in the mechanisms of anorexia nervosa and bulimia  
  Serguei Fetissov, France Speaker
006 Cyclooxygenase-2 (COX-2) gene polymorphism and the risk of mild cognitive impairment in a Southern Chinese community  
  Fu Yan, China, People's Republic of Speaker
     
No. FC-03 - Free Communications
Time: 08.00-09.30
Room: Room 242B
Topic: Psychotic Disorders
Session title: Psychotic Disorders I
  Sven Cichon, Germany Chair
  Geraldo F. Busatto, Brazil Co-Chair
     
001 Bringing 'dealing with stigma' into clinics: Why should 'stigma' not be a part of routine clinical assessment in schizophrenia: Need for objective assessment and quantification  
  Amresh Shrivastava, Canada Speaker
002 Differences among bipolar disorder and schizophrenia: Less and less feasible - breaking a dogma (Kraepelin´s dichotomy)  
  Enrique Galli, Peru Speaker
003 Sensitivity to expressions of pain by schizophrenia patients - neurocognitive and symptoms correlates  
  Mauricio Martins, Portugal Speaker
004 The navel hypothesis of schizophrenia: The meaning of schizophrenia: Synishophrenia instead of schizophrenia?  
  Marko Kraljevic, Croatia Speaker
005 Longitudinal assessment of adolescents with 22q11.2 Deletion Syndrome: Cognitive and cerebral correlates to enhanced risk for psychosis  
  Martin Debbane, Switzerland Speaker
006 Quantitative motor activity in psychotic disorders  
  Sebastian Walther, Switzerland Speaker
     
No. FC-04 - Free Communications
Time: 12.30-14.00
Room: Room 351
Topic: Addictive Disorders
Session title: Addictive Disorders I
  Saroja Krishnaswamy, Malaysia Chair
  N N Co-Chair
     
001 Clinical characteristics of patients with cannabis dependence  
  Alain Dervaux, France Speaker
002 Attention Deficit Hyperactivity Disorder (ADHD) among cocaine / crack abusers: Descriptive study in Martinique (French West Indies)  
  Héloise Delavenne, France Speaker
003 Cortical inhibition in alcohol dependence - examination with the double-pulse transcranial magnetic stimulation  
  Martin Pitterl, Switzerland Speaker
004 Difference in reflection-impulsivity between pathological gamblers and healthy controls  
  Pinhas Dannon, Israel Speaker
006 Changes in Cerebral type 1 Cannabinoid Receptor (CB1-R) availability in Ethanol-dependent patients after binge drinking and abstinence  
  Titia Hompes, Belgium Speaker
     
No. FC-05 - Free Communications
Time: 12.30-14.00
Room: Room 242A
Topic: Psychotic Disorders
Session title: Psychotic Disorders II
  Bernhard Bogerts, Germany Chair
  Jiri Horacek, Czech Republic Co-Chair
     
001 The interhemispheric pathway in hearing: Relationship to auditory hallucinations in schizophrenia  
  Christoph Mulert, USA Speaker
002 Action of Psychotomimetic Ketamine on ongoing y oscillations: EEG, network and cellular features  
  Didier Pinault, France Speaker
003 Analysis of Single Nucleotide Polymorphisms (SNPs) of Serotonin receptors for schizophrenia in Malaysia population  
  Han Chern Loh, Malaysia Speaker
004 Prenatal exposure to infection: A primary mechanism for abnormal dopaminergic development relevant to schizophrenia  
  Joram Feldon, Switzerland Speaker
005 Attentional modulation of external speech perception in patients with hallucinations and delusions  
  Lana Marija Ilankovic, Germany Speaker
006 Prevalence of human parvovirus B19 infection in schizophrenia  
  Mouna Ayachi, Tunisia Speaker
     
No. FC-06 - Free Communications
Time: 12.30-14.00
Room: Room 242B
Topic: Psychopharmacology
Session title: Psychopharmacology I
  F. Markus Leweke, Germany Chair
  David Janowsky, USA Co-Chair
     
001 Effects of chronic lithium administration on renal function in the intellectually disabled  
  David Janowsky, USA Speaker
002 Baseline lipid levels and treatment response to paroxetine and tianeptine in depressed women  
  Marina Sagud, Croatia Speaker
003 Impact of escitalopram compared to amitriptyline on polysomnographically recorded sleep, daytime sleepiness and performance: A randomized, double-blind, placebo-controlled study in healthy male subjects  
  Ulrich Voderholzer, Germany Speaker
004 Enhancing effects of chronic lithium on memory in the rat  
  Dimitrios Kontis, Greece Speaker
005 Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study  
  Alberto Chiesa, Italy Speaker
006 Reduced blood BDNF mRNA levels in depressed patients are normalized by antidepressant treatment  
  Anna Maria Cattaneo, Italy Speaker
 
 

Sunday, 28. June 2009

 next day »
  « Back